Preferred Label : mFOLFOX6-Bevacizumab Regimen;
NCIt synonyms : mFOLFOX6/Bevacizumab; mFOLFOX6-Bevacizumab; mFOLFOX6 Plus Bevacizumab; mFOLFOX6-Avastin; Bevacizumab Plus mFOLFOX6; Modified FOLFOX6-Bevacizumab; Bevacizumab-mFOLFOX6;
NCIt related terms : mFOLFOX6-B; mFOLFOX6-B (bevacizumab-bvzr); mFOLFOX6-B (bevacizumab-adcd); mFOLFOX6-B (bevacizumab-equi); mFOLFOX6-B (bevacizumab-onbe); mFOLFOX6-B (bevacizumab-awwb); mFOLFOX6-B (bevacizumab-maly); mFOLFOX6-B (bevacizumab-aybi); mFOLFOX6-B (L-Leucovorin) (bevacizumab-tnjn); mFOLFOX6-B (bevacizumab-tnjn);
NCIt definition : A regimen consisting of bevacizumab and a modified version of the FOLFOX6 regimen
(mFOLFOX6), which contains leucovorin, infusional fluorouracil and oxaliplatin, that
may be used for the treatment of ampullary and appendiceal adenocarcinoma, colorectal
cancer, and small bowel adenocarcinoma.;
NCI Metathesaurus CUI : CL1905363;
Codes from synonyms : 14783; 127245; 127467; 127541; 127319; 127615; 127171; 127393; 144033; 144032;
Origin ID : C192028;
UMLS CUI : C5784844;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
